Patient Temperature Monitoring Market Size, Share, and Trends 2024 to 2033

Patient Temperature Monitoring Market (By Product: Smart Temperature Monitoring Patches, Table-Top Temperature Monitoring Devices, Wearable Continuous Monitoring Sensors, Handheld Temperature Monitoring Devices, Invasive Temperature Monitoring Devices; By Type: Non-invasive Temperature Monitoring, Invasive Temperature Monitoring; By Application; By End-User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : June 2024
  • Report Code : 2336
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Patient Temperature Monitoring Market 

5.1. COVID-19 Landscape: Patient Temperature Monitoring Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Patient Temperature Monitoring Market, By Product

8.1. Patient Temperature Monitoring Market, by Product, 2024-2033

8.1.1. Smart Temperature Monitoring Patches

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Table-Top Temperature Monitoring Devices

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Wearable Continuous Monitoring Sensors

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Handheld Temperature Monitoring Devices

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Invasive Temperature Monitoring Devices

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Patient Temperature Monitoring Market, By Type

9.1. Patient Temperature Monitoring Market, by Type, 2024-2033

9.1.1. Non-invasive Temperature Monitoring

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Invasive Temperature Monitoring

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Patient Temperature Monitoring Market, By Application 

10.1. Patient Temperature Monitoring Market, by Application, 2024-2033

10.1.1. Blood Transfusion

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Hypothermia

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Anesthesia

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Pyrexia/Fever

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Patient Temperature Monitoring Market, By End-User 

11.1. Patient Temperature Monitoring Market, by End-User, 2024-2033

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Ambulatory Care Centres

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Nursing Facilities

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Home Care Settings

11.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Patient Temperature Monitoring Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.2. Market Revenue and Forecast, by Type (2021-2033)

12.1.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.4. Market Revenue and Forecast, by End-User (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.5.4. Market Revenue and Forecast, by End-User (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Type (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.6.4. Market Revenue and Forecast, by End-User (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.2. Market Revenue and Forecast, by Type (2021-2033)

12.2.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.4. Market Revenue and Forecast, by End-User (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.5.4. Market Revenue and Forecast, by End-User (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Type (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.6.4. Market Revenue and Forecast, by End-User (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Type (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.7.4. Market Revenue and Forecast, by End-User (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Type (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.8.4. Market Revenue and Forecast, by End-User (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.2. Market Revenue and Forecast, by Type (2021-2033)

12.3.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.4. Market Revenue and Forecast, by End-User (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.5.4. Market Revenue and Forecast, by End-User (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Type (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.6.4. Market Revenue and Forecast, by End-User (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Type (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.7.4. Market Revenue and Forecast, by End-User (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Type (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.8.4. Market Revenue and Forecast, by End-User (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.2. Market Revenue and Forecast, by Type (2021-2033)

12.4.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.4. Market Revenue and Forecast, by End-User (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.5.4. Market Revenue and Forecast, by End-User (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Type (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.6.4. Market Revenue and Forecast, by End-User (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Type (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.7.4. Market Revenue and Forecast, by End-User (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Type (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.8.4. Market Revenue and Forecast, by End-User (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.4. Market Revenue and Forecast, by End-User (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Type (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.5.4. Market Revenue and Forecast, by End-User (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Type (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.6.4. Market Revenue and Forecast, by End-User (2021-2033)

Chapter 13. Company Profiles

13.1. Cardinal Health Inc. (US)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. 3M (US)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Koninklijke Philips N.V. (Netherlands)

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Drägerwerk (Germany)

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Hill-Rom Holdings, Inc. (US)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Becton, Dickinson and Company (US)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Omron Healthcare Inc. (Japan)

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Masimo Corporation

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. (US), Braun GmbH (Germany)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Terumo Corporation (Japan)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client